Cargando…
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
BACKGROUND: For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use and breast cancer (BC) risk is still unclear. METHODS: Breast camcer risk associations were estimated from OCP data on 6030 BRCA1 and 3809 BRCA2 mutation carriers using age-dependent C...
Ejemplares similares
-
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020) -
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020) -
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
por: Schrijver, Lieske H., et al.
Publicado: (2021) -
Oral Contraceptive Use in BRCA1 and BRCA2
Mutation Carriers: Absolute Cancer Risks and Benefits
por: Schrijver, Lieske H, et al.
Publicado: (2022) -
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations
por: Terry, Mary Beth, et al.
Publicado: (2019)